Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmaceutics International, Inc. (Pii) is a US-based Contract Development and Manufacturing Organization (CDMO) founded in 1994. They offer comprehensive services including formulation development, dosage form manufacturing, commercial manufacturing, and regulatory support. Pii specializes in complex formulations, including potent compounds, oncology drugs, highly potent compounds, non-aqueous parenterals, and steroids. The company was acquired by Jabil Inc. on February 3, 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmaceutics International, Inc..